The Wall Street Journal reports today that an internal FDA board narrowly voted earlier this month against an Avandia recall. The federal drug regulators appear to be preparing a "black box" warning about the risk of heart attacks instead of removing the diabetes drug from the… Read More
Bloomberg News reports that Johnson & Johnson has agreed to pay $1.25 million to settle one Ortho Evra birth control patch lawsuit. The details of the confidential agreement were made public after the news agency received a copy of settlement documents from a court clerk. Although… Read More
New warnings will be added to the label of Provigil (generic modafinil tablets), indicating that the "wakefulness promoting agent" could lead to the development of Stevens-Johnson Syndrome and other serious side effects. The lawyers at Saiontz & Kirk, P.A. investigate potential lawsuits nationwide for any individuals… Read More
GlaxoSmithKline, PLC was dealt two new blows last week from the Department of Veteran Affairs and the European Medicines Agency, which will ad to their Avandia problems. The V.A. has indicated that they will be severely limiting the use of Avandia among U.S. veterans and Europe's… Read More
The FDA issued an alert yesterday indicating that the diabetes injection Byetta has been associated with serious and potentially fatal side effects for some users. There have been at least 30 reports of acute pancreatitis associated with the injection, which is given to some individuals with… Read More
The FDA announced this week the approval of a generic form of Trileptal, which will be distributed by pharmacists under the name oxcarbazephine. Trileptal side effects have previously been associated with an increased risk of developing the painful and possibly fatal skin disorders, Stevens-Johnson Syndrome (SJS)… Read More
An article yesterday in the New York Times outlines another example of corporations placing profits before the safety of consumers. Despite knowledge that respiratory problems were linked to a dangerous chemical contained in the Stand n Seal Grout Sealer sold at Home Depot stores throughout United… Read More
A new study confirms that the diabetes drugs Actos and Avandia increase the risk of heart failure. Both drugs previously received a "black box" warning about congestive heart failure in June, and they have been the subject of several studies since a report in published in… Read More
The FDA issued a public health notice yesterday about the risk of death associated with the use of Fentora tablets. Side effects could result in overdose or death caused by inappropriate use and over-prescription. The manufacturer, Cephalon, Inc., has agreed to add stronger warnings and improve… Read More
According to a new study presented earlier this week, the diabetes drug Actos may be better than Avandia at controlling blood sugar and lipid levels. Over the past few months, many individuals who have been given Avandia to treat their type 2 diabetes, have been concerned… Read More
